|
|
||||||||

T Cells in Anterior Chamber-Induced Tolerance in CD8+ CTL Responses
1 From the Department of Ophthalmology, Emory University School of Medicine, Atlanta, Georgia.
PURPOSE. Delivery of antigen to the anterior chamber (AC) of the eye induces a systemic form of tolerance, referred to as anterior chamber-associated immune deviation (ACAID). ACAID is characterized by decreases in delayed-type hypersensitivity responses and complement-fixing antibodies on subsequent challenge with an immunogenic form of the antigen. The current study was designed to test whether priming of antigen-specific CD8+ cytotoxic T-lymphocytes (CTLs) are inhibited by injection of soluble antigen into the AC and whether 
T cells play a role in the inhibition of such responses.
METHODS. Antigen was administered through the AC to normal 
T-cell-deficient or reconstituted 
T-cell-deficient mice. Seven days after the AC injection, the mice were primed with antigen in adjuvant and 10 days later, their spleen cells were cultured for 5 to 7 days and the CTL responses measured.
RESULTS. CTL responses were inhibited by antigen delivered through the AC in normal but not 
T-cell-deficient mice. Tolerance was reconstituted in
-chain knockout mice by the adoptive transfer of 
T cells from normal mice. Moreover, spleen cells and splenic 
+ T cells, but not 
- T cells, from mice injected with antigen through the AC inhibited development of CTL responses when cultured together with primed effector T cells.
CONCLUSIONS. These data show, for the first time, that administration of soluble antigen in the AC inhibits development of CD8+ cytotoxic T-cell responses and that 
T cells play a critical role in inhibition of CTL responses.
This article has been cited by other articles:
![]() |
S. Chattopadhyay, J. O'Rourke, and R. E. Cone Implication for the CD94/NKG2A-Qa-1 system in the generation and function of ocular-induced splenic CD8+ regulatory T cells Int. Immunol., April 1, 2008; 20(4): 509 - 516. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brouard, E. Mansfield, C. Braud, L. Li, M. Giral, S.-c. Hsieh, D. Baeten, M. Zhang, J. Ashton-Chess, C. Braudeau, et al. Identification of a peripheral blood transcriptional biomarker panel associated with operational renal allograft tolerance PNAS, September 25, 2007; 104(39): 15448 - 15453. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Ashour and J. Y. Niederkorn {gamma}{delta} T Cells Promote Anterior Chamber-Associated Immune Deviation and Immune Privilege through Their Production of IL-10 J. Immunol., December 15, 2006; 177(12): 8331 - 8337. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. McKenna and J. A. Kapp Accumulation of Immunosuppressive CD11b+ Myeloid Cells Correlates with the Failure to Prevent Tumor Growth in the Anterior Chamber of the Eye J. Immunol., August 1, 2006; 177(3): 1599 - 1608. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Faunce, A. Terajewicz, and J. Stein-Streilein Cutting Edge: In Vitro-Generated Tolerogenic APC Induce CD8+ T Regulatory Cells That Can Suppress Ongoing Experimental Autoimmune Encephalomyelitis J. Immunol., February 15, 2004; 172(4): 1991 - 1995. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Skelsey, E. Mayhew, and J. Y. Niederkorn Splenic B Cells Act as Antigen Presenting Cells for the Induction of Anterior Chamber-Associated Immune Deviation Invest. Ophthalmol. Vis. Sci., December 1, 2003; 44(12): 5242 - 5251. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |